These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Revision of requirements applicable to albumin (human), plasma protein fraction (human), and immune globulin (human). Food and Drug Administration, HHS. Final rule. Fed Regist; 2000 Aug; 65(167):52016-8. PubMed ID: 11067735 [TBL] [Abstract][Full Text] [Related]
6. FDA could OK costly blood standards. An expert says that like chicken soup, removal of white cells from blood supply can't hurt. Hensley S Mod Healthc; 1999 Nov; 29(48):8. PubMed ID: 10662211 [No Abstract] [Full Text] [Related]
7. Red Cross called to task for its handling of blood products. IAPAC Mon; 2001 Feb; 7(2):40-1. PubMed ID: 11302024 [No Abstract] [Full Text] [Related]
8. Revisions to the requirements applicable to blood, blood components and source plasma; confirmation of effective date and technical amendment. Direct final rule; confirmation of effective date and technical amendment. Food and Drug Administration, HHS Fed Regist; 2008 Feb; 73(27):7463-4. PubMed ID: 18389917 [TBL] [Abstract][Full Text] [Related]
9. Opening Pandora's pillbox: using modern information tools to improve drug safety. Gottlieb S Health Aff (Millwood); 2005; 24(4):938-48. PubMed ID: 16012136 [TBL] [Abstract][Full Text] [Related]
10. The development of West Nile virus safety policies by Canadian blood services: guiding principles and a comparison between Canada and the United States. Vamvakas EC; Kleinman S; Hume H; Sher GD Transfus Med Rev; 2006 Apr; 20(2):97-109. PubMed ID: 16565024 [TBL] [Abstract][Full Text] [Related]
11. FDA electronic drug labels to improve patient safety. J Pain Palliat Care Pharmacother; 2006; 20(2):96-7. PubMed ID: 16789334 [No Abstract] [Full Text] [Related]
12. FDA notifications. FDA proposes to revise/update regulations regarding blood and plasma. AIDS Alert; 2008 Feb; 23(2):23-4. PubMed ID: 18574884 [No Abstract] [Full Text] [Related]
13. The FDA uses new technology to improve food security. FDA Consum; 2004; 38(1):3. PubMed ID: 15032182 [No Abstract] [Full Text] [Related]
14. Leavitt: reforms will improve oversight and openness at FDA. FDA Consum; 2005; 39(3):37. PubMed ID: 16127819 [TBL] [Abstract][Full Text] [Related]
15. Sources of drug information: FDA-approved labeling and other official FDA sources. Lindstrom JA Dermatol Ther; 2009; 22(3):246-56. PubMed ID: 19453349 [TBL] [Abstract][Full Text] [Related]
16. Donations to be shared: blood banking groups reach an agreement. Lefton D Am Med News; 1981 Nov 20-27; 24(44):11. PubMed ID: 10253693 [No Abstract] [Full Text] [Related]
17. Specimen-collection standards complete major revisions. Ernst DJ; Szamosi DI MLO Med Lab Obs; 2005 Feb; 37(2):26-9. PubMed ID: 15762350 [No Abstract] [Full Text] [Related]
18. Controlling blood-culture contamination rates. Ernst DJ MLO Med Lab Obs; 2004 Mar; 36(3):14-8; quiz 20-1. PubMed ID: 15061053 [No Abstract] [Full Text] [Related]
19. FDA accuses Red Cross of unsafe practices. Inspections at embattled blood bank turn up 'serious' violations. Becker C Mod Healthc; 2001 Dec; 31(51):10. PubMed ID: 11820197 [No Abstract] [Full Text] [Related]
20. The history and contemporary challenges of the US Food and Drug Administration. Borchers AT; Hagie F; Keen CL; Gershwin ME Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]